Related Experiment Video

Updated: Nov 11, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.8K

Non-coding RNAs related to angiogenesis in gynecological cancer

Neda Rahimian1, Zahra Sadat Razavi2, Fatemeh Aslanbeigi2

  • 1Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences (IUMS), Tehran, Iran.

Gynecologic Oncology
|March 30, 2021
PubMed

Insights

Non-coding RNAs (ncRNAs), especially microRNAs, regulate gene expression and are implicated in gynecological cancer. Understanding their role in angiogenesis could reveal new biomarkers and therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gynecological cancers encompass a range of tumors affecting the female reproductive system.
  • Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), are key regulators of gene expression.
  • miRNAs play critical roles in cellular processes and diseases like cancer, including angiogenesis.

Purpose of the Study:

  • To explore angiogenesis pathways in gynecological cancer.
  • To investigate the role of ncRNAs, particularly miRNAs, in regulating angiogenesis in these cancers.
  • To assess the potential of ncRNAs as biomarkers or therapeutic targets.

Main Methods:

  • Review of existing literature on angiogenesis pathways in gynecological cancers.
  • Analysis of studies detailing the function of ncRNAs (miRNAs and lncRNAs) in gynecological cancer angiogenesis.
  • Exploration of molecular mechanisms underlying miRNA-mediated angiogenesis regulation.

Main Results:

  • miRNAs directly modulate angiogenesis in gynecological cancer by targeting pro-angiogenic factors and signaling pathways.
  • Evidence suggests miRNAs are involved in oncogenesis and metastasis through angiogenesis.
  • The role of long non-coding RNAs (lncRNAs) in this context is emerging but less understood.

Conclusions:

  • Dysregulation of angiogenesis by ncRNAs is a significant factor in gynecological cancer progression.
  • ncRNAs hold promise as potential biomarkers for early detection and prognosis.
  • Targeting ncRNAs involved in angiogenesis presents a novel therapeutic strategy for gynecological malignancies.
Keywords:
AngiogenesisGynecological cancersNon-coding RNAs

More Related Videos

A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells12:48

A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells

Published on: February 16, 2018

7.6K

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.1K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.9K